Omic personality: Implications of stable transcript and methylation profiles for personalized medicine

Genome Medicine

Volumn 7, Issue 1, 2015, Pages

  Tabassum, Rubina ^a,b   Sivadas, Ambily ^a,c   Agrawal, Vartika ^a,d   Tian, Haozheng ^a   Arafat, Dalia ^a   Gibson, Greg ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^d PHILIPS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; RNA; TRANSCRIPTOME;

ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; CAUCASIAN; CELLS BY BODY ANATOMY; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRAIT; GENETIC VARIABILITY; HUMAN; HUMAN GENOME; MALE; NORMAL HUMAN; PERSONALIZED MEDICINE; PHENOTYPE; PILOT STUDY; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RNA ANALYSIS; RNA SEQUENCE; RNA STABILITY; UPREGULATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; GENOMICS; MIDDLE AGED; SEQUENCE ANALYSIS;

ADULT; AFRICAN AMERICANS; CPG ISLANDS; DNA METHYLATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PILOT PROJECTS; PRECISION MEDICINE; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION, GENETIC;

EID: 84955710182     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-015-0209-4     Document Type: Article

References (64)

1. Sander C. Genomic medicine and the future of health care. Science. 2000;287:1977-8.
2. Nicholson JK. Global systems biology, personalized medicine and molecular epidemiology. Mol Sys Biol. 2006;2:52.
3. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA. 2003;100:1896-901.
4. Radich JP, Mao M, Stepaniants S, Biery M, Castle J, Ward T, et al. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics. 2004;83:980-8.
5. Eady JJ, Wortley GM, Wormstone YM, Hughes JC, Astley SB, Foxall RJ, et al. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics. 2005;22:402-11.
6. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HYK, Chen R, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148:1293-307.
7. Brigham KL. Predictive health: the imminent revolution in health care. J Am Geriatr Soc. 2010;58:S298-302.
8. Rask KJ, Brigham KL, Johns MM. Integrating comparative effectiveness research programs into predictive health: a unique role for academic health centers. Acad Med. 2011;86:718-23.
9. Patel CJ, Sivadas A, Tabassum R, Preeprem T, Zhao J, Arafat D, et al. Whole genome sequencing in support of wellness and health maintenance. Genome Med. 2013;5:58.
10. Tabassum R, Cunningham L, Stephens EH, Sturdivant K, Martin GS, Brigham KL, et al. A longitudinal study of health improvement in the Atlanta CHDWB wellness cohort. J Pers Med. 2014;4:489-507.
11. Martino DJ, Tulic MK, Gordon L, Hodder M, Richman TR, Metcalfe J, et al. Evidence for age-related and individual-specific changes in DNA methylation profile of mononuclear cells during early immune development in humans. Epigenetics. 2011;6:1085-94.
12. Wang D, Liu X, Zhou Y, Xie H, Hong X, Tsai HJ, et al. Individual variation and longitudinal pattern of genome-wide DNA methylation from birth to the first two years of life. Epigenetics. 2012;7:594-605.
13. Rakyan VK, Down TA, Maslau S, Andrew T, Yang T-P, Beyan H, et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res. 2010;20:434-9.
14. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H, et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 2010;20:440-6.
15. Maegawa S, Hinkal G, Kim HS, Shen L, Zhang L, Zhang J, et al. Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res. 2010;20:332-40.
16. Bell JT, Tsai PC, Yang TP, Pidsley R, Nisbet J, Glass D, et al. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet. 2012;8:e1002629.
17. Florath I, Butterbach K, Müller H, Bewerunge-Hudler M, Brenner H. Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum Mol Genet. 2014;23:1186-201.
18. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14:R115.
19. Monks SA, Leonardson A, Zhu H, Cundiff P, Pietrusiak P, Edwards S, et al. Genetic inheritance of gene expression in human cell lines. Am J Hum Genet. 2004;75:1094-105.
20. Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M. Mapping complex disease traits with global gene expression. Nat Rev Genet. 2009;10:184-94.
21. Westra HJ, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013;45:1238-43.
22. Lappalainen T, Sammeth M, Friedländer MR, 't Hoen PA, Monlong J, Rivas MA, et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature. 2013;501:506-11.
23. Chaussabel D, Baldwin N. Democratizing systems immunology with modular transcriptional repertoire analyses. Nat Rev Immunol. 2014;14:271-80.
24. Preininger M, Arafat D, Kim J, Nath AP, Idaghdour Y, Brigham KL, et al. Blood-informative transcripts define nine common axes of peripheral blood gene expression. PLoS Genet. 2013;9:e1003362.
25. Wagner JR, Busche S, Ge B, Kwan T, Pastinen T, Blanchette M. The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biol. 2014;15:R37.
26. Trapnell C, Roberts A, Goff L, Perea G, Kim D, Kelley DR, et al. TopHat: discovering splice junctions with RNA-Seq. Nat Protocols. 2012;7:562-78.
27. Mecham B, Nelson PS, Storey JD. Supervised normalization of microarrays. Bioinformatics. 2010;26:1308-15.
28. Wang WC, Lin FM, Chang WC, Lin KY, Huang HD, Lin NS. miRExpress: analyzing high-throughput sequencing data for profiling microRNA expression. BMC Bioinformatics. 2009;10:328.
29. miRExpress software. http://mirexpress.mbc.nctu.edu.tw
30. Leek JT, Scharpf RB, Corrada-Bravo H, Simcha D, Langmead B, Johnson WE, et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet. 2010;11:733-9.
31. Franke L, Jansen RC. eQTL analysis in humans. Methods Mol Biol. 2009;573:311-28.
32. Skelly DA, Ronald J, Akey JM. Inherited variation in gene expression. Annu Rev Genomics Hum Genet. 2009;10:313-32.
33. Chen R, Ren S, Meng T, Aguilar J, Sun Y. Impact of glutathione-S-transferases (GST) polymorphisms and hypermethylation of relevant genes on risk of prostate cancer biochemical recurrence: a meta-analysis. PLoS One. 2013;8:e74775.
34. Gutierrez-Arcelus M, Lappalainen T, Montgomery SB, Buil A, Ongen H, Yurovsky A, et al. Passive and active DNA methylation and the interplay with genetic variation in gene regulation. Elife. 2013;2:e00523.
35. Kamburov A, Pentchev K, Galicka H, Wierling C, Lehrach H, Herwig R. ConsensusPathDB: toward a more complete picture of cell biology. Nucl Acids Res. 2011;39:D712-7.
36. ConsensusPathDB-human. http://consensuspathdb.org.
37. Wang YP, Li KB. Correlation of expression profiles between microRNAs and mRNA targets using NCI-60 data. BMC Genomics. 2009;10:218.
38. Shahab SW, Matyunina LV, Mezencev R, Walker LD, Bowen NJ, Benigno BB, et al. Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach. PLoS One. 2011;6:e22508.
39. Li X, Gill R, Cooper NG, Yoo JK, Datta S. Modeling microRNA-mRNA interactions using PLS regression in human colon cancer. BMC Med Genomics. 2011;4:44.
40. van Iterson M, Bervoets S, de Meijer EJ, Buermans HP, 't Hoen PAC, Menezes RX, et al. Integrated analysis of microRNA and mRNA expression: adding biological significance to microRNA target predictions. Nucl Acids Res. 2013;41:e146.
41. Panousis NI, Gutierrez-Arcelus M, Dermitzakis ET, Lappalainen T. Allelic mapping bias in RNA-sequencing is not a major confounder in eQTL studies. Genome Biol. 2014;15:467.
42. Buil A, Brown AA, Lappalainen T, Viñuela A, Davies MN, Zheng HF, et al. Gene-gene and gene-environment interactions detected by transcriptome sequence analysis in twins. Nat Genet. 2015;47:88-91.
43. Gibson G. The environmental contribution to gene expression profiles. Nat Rev Genet. 2008;9:575-81.
44. Kilpinen H, Dermitzakis ET. Genetic and epigenetic contribution to complex traits. Hum Mol Genet. 2012;21:R24-8.
45. Battle A, Montgomery SB. Determining causality and consequence of expression quantitative trait loci. Hum Genet. 2014;133:727-35.
46. Pai AA, Pritchard JK, Gilad Y. The genetic and mechanistic basis for variation in gene regulation. PLoS Genet. 2015;11:e1004857.
47. Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012;13:358-69.
48. Schmiedel JM, Klemm SL, Zheng Y, Sahay A, Blüthgen N, Marks DS, et al. MicroRNA control of protein expression noise. Science. 2015;348:128-32.
49. Nath AP, Arafat D, Gibson G. Using blood informative transcripts in geographical genomics: impact of lifestyle on gene expression in Fijians. Front Genet. 2012;3:243.
50. Wingo AP, Gibson G. Blood gene expression profiles suggest altered immune function associated with symptoms of generalized anxiety disorder. Brain Behav Immun. 2015;43:184-91.
51. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, Baldwin N, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity. 2008;29:150-64.
52. Fredrickson BL, Grewen KM, Coffey KA, Algoe SB, Firestine AM, Arevalo JM, et al. A functional genomic perspective on human well-being. Proc Natl Acad Sci USA. 2013;110:13684-9.
53. Cole SW. Human social genomics. PLoS Genet. 2014;10:e1004601.
54. Tsang JS, Schwartzberg PL, Kotliarov Y, Biancotto A, Xie Z, Germain RN, et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell. 2014;157:499-513.
55. Pulendran B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat Rev Immunol. 2009;9:741-7.
56. Kim J, Ghasemzadeh N, Eapen DJ, Chung NC, Storey JD, Quyyumi AA, et al. Gene expression profiles associated with acute myocardial infarction and risk of cardiovascular death. Genome Med. 2014;6:40.
57. Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS Genetics. 2013;9:e1003348.
58. Wray NR, Yang J, Hayes BJ, Price AL, Goddard ME, Visscher PM. Pitfalls of predicting complex traits from SNPs. Nat Rev Genet. 2013;14:507-15.
59. Do CB, Hinds DA, Francke U, Eriksson N. Comparison of family history and SNPs for predicting risk of complex disease. PLoS Genet. 2012;8:e1002973.
60. Hood L, Lovejoy JC, Price ND. Integrating big data and actionable health coaching to optimize wellness. BMC Med. 2015;13:4.
61. Bielekova B, Vodovotz Y, An G, Hallenbeck J. How implementation of systems biology into clinical trials accelerates understanding of diseases. Front Neurol. 2014;5:102.
62. Abate N, Sallam HS, Rizzo M, Nikolic D, Obradovic M, Bjelogrlic P, et al. Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome. Curr Pharm Des. 2014;20:4961-9.
63. Owecki M, Nikisch E, Miczke A, Pupek-Musialik D, Sowiński J. Serum resistin is related to plasma HDL cholesterol and inversely correlated with LDL cholesterol in diabetic and obese humans. Neuro Endocrinol Lett. 2010;31:673-8.
64. Rashid S. What do high blood resistin levels mean for patients on statin therapy? Expert Rev Cardiovasc Ther. 2013;11:255-7.